According to the Zhitong Finance App, Sinopharm Holdings (01099.HK) announced that Sinopharm achieved total operating revenue of about 55.066 billion yuan in the first three quarters of 2026, a year-on-year decrease of 0.11%; net profit attributable to shareholders of listed companies was about 952 million yuan, a year-on-year decrease of 0.48%; and basic earnings per share were 1.56 yuan. In the third quarter of 2026, we achieved operating income of 18.80 billion yuan, an increase of 2.57% year on year; net profit attributable to shareholders of listed companies was 346 million yuan, an increase of 18.91% year on year.

According to the Zhitong Finance App, Sinopharm Holdings (01099.HK) announced that Sinopharm achieved total operating revenue of about 55.066 billion yuan in the first three quarters of 2026, a year-on-year decrease of 0.11%; net profit attributable to shareholders of listed companies was about 952 million yuan, a year-on-year decrease of 0.48%; and basic earnings per share were 1.56 yuan. In the third quarter of 2026, we achieved operating income of 18.80 billion yuan, an increase of 2.57% year on year; net profit attributable to shareholders of listed companies was 346 million yuan, an increase of 18.91% year on year.